Nobuo Negoro

962 total citations
37 papers, 756 citations indexed

About

Nobuo Negoro is a scholar working on Rheumatology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nobuo Negoro has authored 37 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 11 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nobuo Negoro's work include Systemic Lupus Erythematosus Research (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Nobuo Negoro is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Nobuo Negoro collaborates with scholars based in Japan and United States. Nobuo Negoro's co-authors include Yoshiharu Kanayama, Takatoshi Inoue, M. Okamura, T. Takeda, Mikio Okamura, Yoshio Kanayama, Tadanao Takeda, Katsuyuki Miura, John G. Curd and Tomoaki Iwai and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Annals of the Rheumatic Diseases.

In The Last Decade

Nobuo Negoro

35 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuo Negoro Japan 13 414 383 155 138 118 37 756
Hiroko Kanda Japan 18 300 0.7× 273 0.7× 55 0.4× 105 0.8× 130 1.1× 55 823
Fokko van der Woude Germany 12 314 0.8× 186 0.5× 49 0.3× 207 1.5× 177 1.5× 23 1.1k
Lihua Wu China 13 350 0.8× 401 1.0× 110 0.7× 413 3.0× 87 0.7× 28 825
Maria Silk United States 10 376 0.9× 576 1.5× 197 1.3× 113 0.8× 117 1.0× 18 884
E L Nasonov Russia 14 247 0.6× 563 1.5× 121 0.8× 49 0.4× 100 0.8× 135 853
Edmund Kwok‐Ming Li China 15 412 1.0× 482 1.3× 30 0.2× 139 1.0× 271 2.3× 21 893
Carly Barnett United Kingdom 4 302 0.7× 474 1.2× 171 1.1× 180 1.3× 47 0.4× 9 644
Robert S Flanc Australia 8 146 0.4× 318 0.8× 56 0.4× 309 2.2× 138 1.2× 9 629
Makoto Sugihara Japan 17 173 0.4× 198 0.5× 88 0.6× 23 0.2× 131 1.1× 92 785
Toru Yoshinari Japan 12 181 0.4× 283 0.7× 57 0.4× 30 0.2× 173 1.5× 20 855

Countries citing papers authored by Nobuo Negoro

Since Specialization
Citations

This map shows the geographic impact of Nobuo Negoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Negoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Negoro more than expected).

Fields of papers citing papers by Nobuo Negoro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Negoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Negoro. The network helps show where Nobuo Negoro may publish in the future.

Co-authorship network of co-authors of Nobuo Negoro

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Negoro. A scholar is included among the top collaborators of Nobuo Negoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Negoro. Nobuo Negoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okamura, Mikio, Yoshiharu Kanayama, Nobuo Negoro, Takatoshi Inoue, & Tadanao Takeda. (2015). Long-Term Effects of Calcium Antagonists and Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Renal Failure of IgA Nephropathy. Contributions to nephrology. 90. 161–165.
2.
3.
Enomoto, Masaru, Nobuo Negoro, Hideki Fujii, et al.. (2010). Hepatitis B-associated cryoglobulinemia and antiphospholipid antibodies. Kanzo. 51(8). 454–456. 1 indexed citations
4.
Sunami, Kishiko, et al.. (2009). A Case of Churg-Strauss Syndrome Following Corticosteroid Withdrawal. Nippon Jibiinkoka Gakkai Kaiho. 112(6). 487–490.
5.
Negoro, Nobuo, K. Kitamoto, Tomoaki Iwai, et al.. (2008). Microarray Analysis of Glomerular Gene Expression in Murine Lupus Nephritis. Journal of Pharmacological Sciences. 106(1). 56–67. 75 indexed citations
6.
Sunami, Kishiko, et al.. (2005). A Case of Suspected Wegener's Granulomatosis Beginning with Repeated Attacks of Vertigo. Practica Oto-Rhino-Laryngologica. 98(6). 441–445. 1 indexed citations
7.
Komiya, Toshiyuki, Nobuo Negoro, Kyoko Kondo, et al.. (2004). Clinical significance of von Willebrand factor in patients with adult dermatomyositis. Clinical Rheumatology. 24(4). 352–357. 13 indexed citations
8.
Kono, Takeshi, et al.. (2000). Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent. Journal of the American Academy of Dermatology. 42(3). 519–520. 16 indexed citations
9.
Okamura, Makoto, Masaaki Konishi, Nobuo Negoro, et al.. (1997). Enhanced gene expression of scavenger receptor in peripheral blood monocytes from patients on cuprophane haemodialysis. Nephrology Dialysis Transplantation. 12(6). 1167–1172. 11 indexed citations
10.
Haraguchi, Masashi, et al.. (1997). Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo. Kidney International. 51(6). 1838–1846. 12 indexed citations
11.
Kanayama, Yoshiharu, et al.. (1996). Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1303(3). 199–206. 54 indexed citations
12.
Negoro, Nobuo, Yoshiharu Kanayama, Yoshio Konishi, et al.. (1995). Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.. Journal of Clinical Investigation. 95(3). 1140–1150. 52 indexed citations
13.
Kanayama, Yoshiharu, et al.. (1995). GENE EXPRESSION OF ENDOTHELIN RECEPTORS IN AORTIC CELLS FROM CYCLOSPORINE‐INDUCED HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 22(6-7). 404–409. 11 indexed citations
14.
Negoro, Nobuo, Yoshiharu Kanayama, Yoshio Konishi, et al.. (1994). Angiotensin-converting enzyme inhibitor increases angiotensin type 1A receptor gene expression in aortic smooth muscle cells of spontaneously hypertensive rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1226(1). 19–24. 4 indexed citations
15.
Kanayama, Yoshiharu, et al.. (1992). INCREASED Na+/H+ EXCHANGE ACTIVITY IN VASCULAR SMOOTH MUSCLE CELLS OF SPONTANEOUSLY HYPERTENSIVE RATS AND POSSIBLE INVOLVEMENT OF PROTEIN KINASE C. Clinical and Experimental Pharmacology and Physiology. 19(3). 171–176. 6 indexed citations
16.
Kanayama, Yoshiharu, et al.. (1991). Angiotensin II induced biphasic inositol 1,4,5-triphosphate response in rat vascular smooth muscle cells. European Journal of Pharmacology Molecular Pharmacology. 208(1). 93–95. 1 indexed citations
17.
Okamura, Mikio, et al.. (1990). Corticosteroid- and Furosemide-Induced Increase in Proteinuria in Nephrosis. ˜The œNephron journals/Nephron journals. 56(4). 427–430. 1 indexed citations
18.
Negoro, Nobuo, et al.. (1988). Expression of c-myc proto-oncogene in hearts and cultured smooth muscle cells of spontaneously hypertensive rats. Journal of Hypertension. 6(4). S128–130. 9 indexed citations
19.
Kanayama, Yoshiharu, et al.. (1987). Serum levels of interferons in patients with systemic lupus erythematosus.. PubMed. 70(3). 562–9. 154 indexed citations
20.
Negoro, Nobuo, Mikio Okamura, Masakazu Kohno, et al.. (1982). A case of hydralazine-induced lupus erythematosus with circulating antibodies to native DNA.. PubMed. 28(2). 149–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Kanda Breakdown of academic impact, for papers by Fokko van der Woude Breakdown of academic impact, for papers by Lihua Wu Breakdown of academic impact, for papers by Maria Silk Breakdown of academic impact, for papers by E L Nasonov Breakdown of academic impact, for papers by Edmund Kwok‐Ming Li Breakdown of academic impact, for papers by Carly Barnett Breakdown of academic impact, for papers by Robert S Flanc Breakdown of academic impact, for papers by Makoto Sugihara Breakdown of academic impact, for papers by Toru Yoshinari
Rankless by CCL
2026